BioSpace News Archive

BioCapital

Health Care Valuations Based on QALY Undercut the Fight Against Chronic Disease

Ethical questions loom over innovative efforts that can save lives

November 21, 2019
·
3 min read
Business

ViiV Healthcare announces exclusive licensing agreement with the National Institutes of Health for investigational “bNAb” with potential for long-acting HIV treatment and prevention

Broadly neutralising antibodies are antibodies that can recognise and block the entry of different strains of HIV into healthy cells.

November 21, 2019
·
3 min read
FDA

Merit Medical Receives FDA Breakthrough Device Designation for WRAPSODY™ Endovascular Stent Graft System

The WRAPSODY system is a flexible, self-expanding endoprosthesis for which Merit intends to seek indication for use in hemodialysis patients for the treatment of stenosis within the central veins of the outflow circuit of an arteriovenous fistula (AVF) up to the superior vena cava.

November 21, 2019
·
5 min read
Drug Development

Pivotal data from Phase 3 study of sutimlimab in cold agglutinin disease to be presented at ASH 2019 late-breaking session

Sutimlimab, an investigational targeted C1s inhibitor, met its primary efficacy endpoint in Phase 3 trial for patients with cold agglutinin disease

November 21, 2019
·
6 min read
Thrombosis Research Institute (TRI) Launches Innovative Risk Calculator for Predicting Stroke, Major Bleeding and Mortality in Atrial Fibrillation Over Two Years

Rapidly predicts differences in risk when treated with different anticoagulants or not treated

November 21, 2019
·
2 min read
Genetown

Boston Scientific to Participate in Evercore ISI and Piper Jaffray Healthcare Conferences

The session will begin at approximately 11:00 a.m. EST.

November 21, 2019
·
1 min read
Pharm Country

Enzychem Lifesciences Presents EC-18 NASH Development Update at The Liver Meeting 2019

Enzychem Lifesciences Corporation (KOSDAQ: 183490), highlighted promising nonclinical data from its NASH candidate EC-18 at The Liver Meeting 2019, hosted annually by the American Association for the Study of Liver Diseases (AASLD).

November 21, 2019
·
2 min read
Business

LightIntegra Technology appoints new board member

LightIntegra Technology announced today that it has appointed Dr. Andrew Heaton, to its board of directors effective November 21, 2019.

November 21, 2019
·
2 min read
Drug Development

Initiation of a Phase 2 Multicenter Study of 18F-APN-1607, a Novel Diagnostic PET Imaging Tracer for the Characterization of Tau Burden in Alzheimer’s Disease

APRINOIA Therapeutics, Inc. announced today that it has initiated a Phase 2 multicenter, multinational study of 18F-APN-1607 in the US for its lead tau positron emission tomography (PET) tracer in Alzheimer’s Disease (AD).

November 21, 2019
·
2 min read
Purolite’s Praesto® Agarose-based Chromatography Resins Move Into the Commercial Manufacturing of FDA-Approved Biotherapeutics

Purolite Ltd., a leading manufacturer of resin-based separation, purification and extraction technologies, today announces that its Praesto® agarose-based chromatography resin range is being utilised for the commercial manufacturing of FDA-approved biotherapeutics

November 21, 2019
·
1 min read